Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 10:35 am Sale | 2022-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | JANUS HENDERSON GROUP PLC JHG | 2,114,519 2.200% | -3,628,878 (-63.18%) | Filing History |
| 2023-01-31 4:00 pm Purchase | 2022-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Medicxi Growth I LP | 19,963,157 21.100% | 1,839,265 (+10.15%) | Filing History |
| 2022-11-23 12:28 pm Purchase | 2022-11-14 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital, LLC | 5,232,279 5.500% | 5,232,279 (New Position) | Filing History |
| 2022-06-16 5:24 pm Purchase | 2022-06-06 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | BIOTECHNOLOGY VALUE FUND L P | 6,894,345 7.300% | 6,894,345 (New Position) | Filing History |
| 2022-02-14 08:07 am Purchase | 2021-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | INDEX VENTURES LIFE VI (JERSEY) L.P. | 9,961,789 11.100% | 9,961,789 (New Position) | Filing History |
| 2022-02-11 1:47 pm Purchase | 2021-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | JANUS HENDERSON GROUP PLC JHG | 5,743,397 6.400% | 5,743,397 (New Position) | Filing History |
| 2022-02-08 08:27 am Purchase | 2021-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Medicxi Growth I LP | 18,123,892 20.160% | 18,123,892 (New Position) | Filing History |